Depressive Disorder, Major: all 2,805 studies
Page 19 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive DisorderStatus unknownNCT03899194Not applicable
- Confirmation Bias Towards Treatments of Depressive Disorders in Social TaggingCompletedNCT03899168Not applicable
- Floatation-REST (Reduced Environmental Stimulation Therapy) for Anxiety and DepressionActive, not recruitingNCT03899090Not applicable
- Imaging mGluR5 and Synaptic Density in Psychiatric DisordersCompletedNCT03898297
- Gut Feeling: Understanding the Mechanisms Underlying the Antidepressant Properties of ProbioticsCompletedNCT03893162Not applicable
- DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using AripiprazoleStatus unknownNCT03881449Phase 4
- The Effect of Probiotic Supplementation on the Mental Status, Inflammation, and Intestinal Barrier in Major Depressive Disorder Patients Using Gluten-free or Gluten-containing DietStatus unknownNCT03877393Not applicable
- Scopolamine in Healthy VolunteersStatus unknownNCT03874130Phase 1
- Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital ScaleTerminatedNCT03872492Not applicable
- N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical SubtypesCompletedNCT03871088Not applicable
- Nitrous Oxide for the Treatment of Major Depressive DisorderCompletedNCT03869736Phase 2
- LSD Therapy for Persons Suffering From Major DepressionCompletedNCT03866252Phase 2
- Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)WithdrawnNCT03855865Phase 3
- DELPhI Evaluation of Psychiatric ConditionsWithdrawnNCT03842345
- Study With Vortioxetine on Emotional Functioning in Patients With DepressionCompletedNCT03835715Phase 4
- Glabellar Botulinum Toxin Injections for the Treatment of Geriatric DepressionWithdrawnNCT03833063Phase 1
- Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-DepressionCompletedNCT03832283Not applicable
- A Relative Bioavailability Food Effect Study of LY03005CompletedNCT03822065Phase 1
- ROOM-LIGHT: Effect of a Dynamic Lighting System in Depressed InpatientsCompletedNCT03821506Not applicable
- Lithium Therapeutic Drug Monitoring; Once Daily Vs Twice Daily Dosing and the Impact of Kidney FunctionStatus unknownNCT03811860Not applicable
- Accelerated Intermittent Theta-Burst Stimulation for Opiate Use DisorderWithdrawnNCT03804619Not applicable
- The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental HealthCompletedNCT03795688
- Coil Positioning in Navigated Transcranial Magnetic Stimulation Feasibility in Depression Patients TrialCompletedNCT03795051Not applicable
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia IndividualsStatus unknownNCT03790085Early Phase 1
- Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive DisorderSuspendedNCT03787290Phase 2
- A Transdiagnostic Sleep and Circadian Treatment for Major Depressive DisorderStatus unknownNCT03786731Not applicable
- Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedNCT03785652Phase 1
- EXperimental Paradigm to Investigate Expectation Change in Depression 4CompletedNCT03780881Not applicable
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic AssessmentCompletedNCT03779789Phase 4
- A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant WomenCompletedNCT03774641
- Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD), WithdrawnWithdrawnNCT03769350Not applicable
- Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With DepressionCompletedNCT03766867Phase 2
- Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and DepressionWithdrawnNCT03758495
- Effect of Vitamin D Administration Along With SSRIs in Patients With Major Depressive DisorderStatus unknownNCT03754712Not applicable
- Comparative Effectiveness of Pharmacogenomics for Treatment of DepressionCompletedNCT03749629Not applicable
- Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar DisorderCompletedNCT03748446Early Phase 1
- Sleep Subtypes in Adolescent DepressionCompletedNCT03742960Not applicable
- Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride TabletsCompletedNCT03739632Phase 2
- Cognitive Behavioural Therapy for the Treatment of Late Life DepressionCompletedNCT03735576Not applicable
- A Study of LY03005 vs PristiqCompletedNCT03733574Phase 1
- Role of Omega-3 Polyunsaturated Fatty Acid in the Management of Major Depressive Disorder.CompletedNCT03732378Not applicable
- Group CBT and Exercise in Management of DepressionTerminatedNCT03731728Not applicable
- Research on the Effects of Combined Neurostimulation Protocols on StressCompletedNCT03722095Not applicable
- Ketamine for Major Depressive DisorderStatus unknownNCT03721900Phase 1
- Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHDCompletedNCT03721588
- Efficacy and Safety of Accelerated Transcranial Magnetic Stimulation With H1-coil (dTMS)CompletedNCT03718013Not applicable
- Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of ConceptCompletedNCT03715127Phase 2
- An Eye Tracking Study of Affective Disorder Patients With Suicide RiskStatus unknownNCT03711045
- Maintenance of Response After rTMS for Depression Using tDCSCompletedNCT03708159Not applicable
- Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT TreatmentStatus unknownNCT03703414
- The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal CognitionTerminatedNCT03693105Phase 2/3
- Efficacy of Light Therapy Device LUMINETTE® in Major Depressive DisorderCompletedNCT03685942Not applicable
- Triple Chronotherapy in AdolescentsCompletedNCT03679962Not applicable
- Ketamine Versus Electroconvulsive Therapy in DepressionSuspendedNCT03674671Phase 3
- Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer PatientsCompletedNCT03674138Not applicable
- Prediction of SSRI Treatment in Major Depression.Status unknownNCT03670823
- Ketamine Co-induction for Patients With Major Depressive DisorderStatus unknownNCT03666494Phase 4
- Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and SuicideStatus unknownNCT03666390Not applicable
- Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use DisorderCompletedNCT03658330Phase 2
- Neuro-Cardiac-Guided Transcranial Magnetic Stimulation: Replication and Dose-response.CompletedNCT03652597Not applicable
- Gender Dysphoria Among Adolescents (Norwegian Title: Kjønnsdysfori Blant Ungdom)Status unknownNCT03643120Not applicable
- A Study in Patients With Major Depressive DisorderActive, not recruitingNCT03642964Phase 2
- Investigating Predictors of Treatment Response in Treatment-Resistant Depression (TRD) With Interleaved TMS/fMRICompletedNCT03642522Not applicable
- The Antidepressant Advisor StudyStatus unknownNCT03628027Phase 2
- Biomarkers of Theta Burst Stimulation in Major Depressive DisorderStatus unknownNCT03626181Not applicable
- Effects of Cannabis Abstinence on Symptoms and Cognition in DepressionCompletedNCT03624933Not applicable
- Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM)CompletedNCT03624621Not applicable
- iCare4Depression: Effectiveness of a Blended Cognitive-Behavioral Therapy in Routine PracticeStatus unknownNCT03623724Not applicable
- A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on DepressionStatus unknownNCT03623711Early Phase 1
- Modafinil's Effects on Cognition in Remitted MDDTerminatedNCT03620253Phase 3
- A Study of Pregnant and Postpartum Women With and Without Mood DisordersCompletedNCT03615794
- A Multimodal Neuroimaging Study of Brain Activation Patterns Under KetamineCompletedNCT03609190Early Phase 1
- Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY StudyStatus unknownNCT03606850Not applicable
- Olfactory Training and Emotional StateCompletedNCT03605524Not applicable
- Probing Prefrontal Cortex Hemodynamic Alterations for Major Depression DisorderStatus unknownNCT03595020
- Pharmacogenomic Testing to Optimize Antidepressant Drug TherapyCompletedNCT03591224Not applicable
- Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 DiabetesWithdrawnNCT03580967Phase 4
- Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:Active, not recruitingNCT03573349Early Phase 1
- Antidepressive Effect on 5 Herz (Hz) rTMS Over Dorsomedial Prefrontal Cortex and Left Dorsolateral Prefrontal CortexCompletedNCT03571412Not applicable
- MARt-Depression TrialCompletedNCT03564067Not applicable
- The Study of Mindfulness-based Cognitive Therapy and Major Depressive DisorderStatus unknownNCT03558256Not applicable
- Transcranial Direct Current Stimulation in Major DepressionCompletedNCT03556124Not applicable
- Real-life Effectiveness of Vortioxetine in DepressionCompletedNCT03555136
- Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive DisorderCompletedNCT03554447Not applicable
- Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive DisorderActive, not recruitingNCT03554174Phase 1
- Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy SubjectsCompletedNCT03551288Phase 1
- Pharmacogenetics Informed Tricyclic Antidepressant Dosing (PITA)CompletedNCT03548675Phase 4
- tDCS as add-on Treatment to Cognitive-Behavior Therapy in People With MDDStatus unknownNCT03548545Not applicable
- Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive DisorderTerminatedNCT03537547Phase 4
- Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine StudyTerminatedNCT03523767Phase 1
- Combined Sertraline and Ketoprofen Administration in Major Depressive DisorderCompletedNCT03514810Phase 1
- Cycloserine rTMS Plasticity Augmentation in DepressionCompletedNCT03511599Phase 1
- Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy VolunteersCompletedNCT03504475Phase 1
- The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive DisorderTerminatedNCT03487198Phase 3
- The Study of Effectiveness of rTMS on Rumination and Anhedonia in Patients With Major Depressive DisorderCompletedNCT03468686Not applicable
- Targeting Cognitive Immunization in DepressionCompletedNCT03460574Not applicable
- Acupuncture in Depression: From the Clinical Trial, Biomarkers to Molecular BiologyCompletedNCT03452384Not applicable
- Effect of 4-session Metacognitive Training in Chinese Adult Outpatients With Schizophrenia Spectrum Disorders and Major Depressive DisorderCompletedNCT03449394Not applicable
- DBS for DepressionActive, not recruitingNCT03437928Not applicable
- Does Nurse Semi Structured Interview Added to a rTMS Improve Patients With Major Depressive Disorder?CompletedNCT03436823Not applicable